Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016

[1]  Lin Wang,et al.  Mixed histiocytosis: A case report and published work review , 2018, The Journal of dermatology.

[2]  C. Fletcher,et al.  Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling , 2018, Modern Pathology.

[3]  F. Munier,et al.  Juvenile xanthogranuloma involving concurrent iris and skin: Clinical, pathological and molecular pathological evaluations , 2017, American journal of ophthalmology case reports.

[4]  A. Tzankov,et al.  PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma , 2018, Annals of Hematology.

[5]  P. Thorner,et al.  BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma. , 2017, Human pathology.

[6]  Joseph D Khoury,et al.  Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease , 2017, Modern Pathology.

[7]  A. Rosenwald,et al.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases , 2017, Virchows Archiv.

[8]  A. Tzankov,et al.  Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease , 2017, Virchows Archiv.

[9]  P. Parkin,et al.  The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case‐control study , 2017, Journal of the American Academy of Dermatology.

[10]  R. Cason,et al.  Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations , 2017, Modern Pathology.

[11]  D. Wheeler,et al.  Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma , 2017, Oncotarget.

[12]  A. Wicki,et al.  Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations. , 2017, Blood.

[13]  J. D. van der Walt,et al.  Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow , 2017, Annals of Hematology.

[14]  B. Rollins,et al.  Histiocytoses: emerging neoplasia behind inflammation. , 2017, The Lancet. Oncology.

[15]  H. Deeg,et al.  Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  O. Abdel-Wahab,et al.  Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses , 2016 .

[17]  T. Qiu,et al.  High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms , 2016, Oncotarget.

[18]  A. Cherry,et al.  Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. , 2016, Human pathology.

[19]  O. Abdel-Wahab,et al.  Histiocytic neoplasms in the era of personalized genomic medicine , 2016, Current opinion in hematology.

[20]  R. Shackelford,et al.  Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment , 2016, European journal of haematology.

[21]  B. Woda,et al.  Somatic mutations in histiocytic sarcoma identified by next generation sequencing , 2016, Virchows Archiv.

[22]  A. Fischer,et al.  Revised Classification of Histiocytoses and Neoplasms of the Macrophage-dendritic Cell Lineages Histiocyte and Dendritic Cell Lineages the " L " (langerhans) Group , 2022 .

[23]  S. Fröhling,et al.  Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling , 2016, Leukemia.

[24]  A. Hoischen,et al.  Independent development of lymphoid and histiocytic malignancies from a shared early precursor , 2016, Leukemia.

[25]  M. Kluk,et al.  Rosai–Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation , 2016, Head and Neck Pathology.

[26]  B. Taylor,et al.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. , 2016, Cancer discovery.

[27]  J. Haroche,et al.  Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. , 2015, Hematology. American Society of Hematology. Education Program.

[28]  V. Bigley,et al.  Cell(s) of Origin of Langerhans Cell Histiocytosis. , 2015, Hematology/oncology clinics of North America.

[29]  L. Weiss,et al.  BRAF V600E mutation-specific immunohistochemistry is a rare finding in dendritic cell- and histiocyte-derived tumors , 2015, Leukemia & lymphoma.

[30]  M. Merad,et al.  Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? , 2015, British journal of haematology.

[31]  M. Hicks,et al.  Differentiating skin-limited and multisystem Langerhans cell histiocytosis. , 2014, The Journal of pediatrics.

[32]  K. Hoang-Xuan,et al.  Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib , 2014, Neurology.

[33]  H. Cualing,et al.  Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. , 2014, Cancer control : journal of the Moffitt Cancer Center.

[34]  A. Tzankov,et al.  Unique Composite Hematolymphoid Tumor Consisting of a Pro-T Lymphoblastic Lymphoma and an Indeterminate Dendritic Cell Tumor: Evidence for Divergent Common Progenitor Cell Differentiation , 2014, Pathobiology.

[35]  Larissa V Furtado,et al.  High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. , 2014, Blood.

[36]  H. Cha,et al.  Frequent detection of BRAFV600E mutations in histiocytic and dendritic cell neoplasms , 2014, Histopathology.

[37]  A. Tzankov,et al.  Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor , 2014, Leukemia.

[38]  B. Rollins,et al.  Somatic activating ARAF mutations in Langerhans cell histiocytosis. , 2014, Blood.

[39]  M. Merad,et al.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups , 2014, The Journal of experimental medicine.

[40]  J. B. Oliveira.  The expanding spectrum of the autoimmune lymphoproliferative syndromes , 2013, Current opinion in pediatrics.

[41]  Annette S. Kim,et al.  Hemophagocytic Lymphohistiocytosis An Update on Diagnosis and Pathogenesis , 2013 .

[42]  Shigeo Nakamura,et al.  Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. , 2013, Journal of clinical and experimental hematopathology : JCEH.

[43]  M. Copin,et al.  High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. , 2012, Blood.

[44]  B. Cheson,et al.  Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor , 2011, Journal of cutaneous pathology.

[45]  D. Parham,et al.  Langerhans Cell Histiocytosis Preceding the Development of Juvenile Xanthogranuloma: A Case and Review of Recent Developments , 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[46]  E. Jaffe,et al.  Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases , 2011, Modern Pathology.

[47]  Dan M. Jones.  Histiocytic and Dendritic Cell Neoplasms. , 2010, Surgical pathology clinics.

[48]  W. Hahn,et al.  Recurrent BRAF mutations in Langerhans cell histiocytosis. , 2010, Blood.

[49]  L. Rybak,et al.  Primary Rosai-Dorfman Disease of Bone: A Clinicopathologic Study of 15 Cases , 2010, The American journal of surgical pathology.

[50]  U. Surti,et al.  Clinicopathologic Features of Histiocytic Lesions following ALL, with a Review of the Literature , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[51]  M. Datto,et al.  Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a ‘transdifferentiation’ during the clonal evolution , 2010, Leukemia & lymphoma.

[52]  R. Warnke,et al.  Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. , 2008, Blood.

[53]  W. Klapper,et al.  Clonality in juvenile xanthogranuloma. , 2007, The American journal of surgical pathology.

[54]  K. Chang,et al.  Extranodal Rosai-Dorfman Disease Involving the Bone Marrow: A Case Report , 2006, The American journal of surgical pathology.

[55]  S. Bray,et al.  Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? , 2006, Human pathology.

[56]  E. Jaffe,et al.  Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative Syndrome , 2005, The American journal of surgical pathology.

[57]  A. Attarbaschi,et al.  Histiocytosis following T-acute lymphoblastic leukemia: A BFM study , 2005, Leukemia & lymphoma.

[58]  R. Egeler,et al.  Histiocytic disorders of children and adults , 2005 .

[59]  K. Chang,et al.  Histiocytic lesions involving the bone marrow. , 2003, Seminars in diagnostic pathology.

[60]  B. Beuthien-Baumann,et al.  Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. , 2002, Clinical lymphoma.

[61]  R. Warnke,et al.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases , 2002, Histopathology.

[62]  S. Fosså,et al.  Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. , 2000, Journal of the National Cancer Institute.

[63]  S. Dement.  Association between mediastinal germ cell tumors and hematologic malignancies: an update. , 1990, Human pathology.